Trovagene Inc (TROV) - Medical Equipment - Deals and Alliances Profile

Date: October 16, 2018
Pages: 62
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: TC61CF2ED6EEN
Leaflet:

Download PDF Leaflet

Trovagene Inc (TROV) - Medical Equipment - Deals and Alliances Profile
Summary

Trovagene Inc (Trovagene) is a clinical-stage cancer therapeutics company that focuses on improved cancer care using its technology in tumor genomics. Its lead product, PCM-075, is a polo-like kinase 1 (PLK1) inhibitor that helps treat solid tumor cancers and multiple hematologic malignancies. The company’s pipeline products include TROV-052 for the treatment of acute myeloid leukemia; and TROV-053 for the treatment of castration-resistant prostate cancer. Trovagene harnesses its proprietary Precision Cancer Monitoring (PCM) technology to analyze circulating tumor DNA (ctDNA) and clinically actionable markers for the detection and quantitation of oncogene mutations, which enable it to discover patients with possibility to respond to targeted cancer therapies. Trovagene is headquartered in San Diego, California, the US.

Trovagene Inc (TROV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Trovagene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deal Details
Asset Purchase
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics
Venture Financing
TrovaGene Secures USD15 Million in Venture Funding
Partnerships
Trovagene Enters Into Licensing Agreement with GenSignia IP
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test
Trovagene Enters into Agreement with Novogene
Trovagene Enters into Agreement for Trovera
Trovagene Enters into Agreement with AstraZeneca
Trovagene Enter into Agreements for Trovera
Trovagene Enters into Agreement with Boreal Genomics
Trovagene Enters into Agreement with USC Norris Comprehensive Cancer Center
Trovagene Enters into Research Agreement with University of Michigan Comprehensive Cancer Center
Trovagene Enters into Patent Option Agreement with Massachusetts Institute of Technology
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University
Equity Offering
Trovagene Raises USD18 Million in Public Offering of Shares
Trovagene Raises USD4.5 Million in Public Offering of Shares and Warrants
Trovagene Plans to Raise Funds through Public Offering of Shares upon Exercise of Warrants
Trovagene Raises USD7.1 Million in Private Placement of Shares and Warrants
Trovagene Raises USD40.3 Million in Public Offering of Shares
Trovagene Completes Public Offering of Shares for USD23 Million
Trovagene Completes Private Placement Of Shares For US$15 Million
Trovagene Completes Private Placement Of Units For US$4 Million
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million
Trovagene Inc - Key Competitors
Trovagene Inc - Key Employees
Trovagene Inc - Locations And Subsidiaries
Head Office
Recent Developments
Financial Announcements
Aug 03, 2018: Trovagene announces second quarter 2018 highlights and financial results
May 08, 2018: Trovagene Announces First Quarter 2018 Highlights and Financial Results
Feb 26, 2018: Trovagene Announces Fourth Quarter and Full-Year 2017 Results
Nov 09, 2017: Trovagene Announces Third Quarter 2017 Company Highlights and Financial Results
Aug 09, 2017: Trovagene Announces Second Quarter 2017 Company Highlights and Financial Results
May 10, 2017: Trovagene Announces First Quarter 2017 Company Highlights and Financial Results
Mar 15, 2017: Trovagene Reports Fourth Quarter and Year End 2016 Financial Results
Corporate Communications
Jun 22, 2018: Trovagene Announces Senior Management Change
Sep 20, 2017: Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis
Apr 13, 2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board
Legal and Regulatory
Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements
Product News
Jan 03, 2018: Trovagene to Present at the Biotech Showcase Annual Conference
Other Significant Developments
Jul 12, 2017: Trovagene Announces Agreement with Novogene for NextCollect in China
Jun 22, 2017: Trovagene Announces Agreement with Global Biopharmaceutical Company to Utilize Trovera ctDNA Tests and Services in Cancer Clinical Trials
Jan 12, 2017: Trovagene Announces Broadening Network of Commercial Distributors
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Trovagene Inc, Medical Equipment, Key Facts, 2017
Trovagene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Trovagene Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Trovagene Inc, Deals By Market, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics
TrovaGene Secures USD15 Million in Venture Funding
Trovagene Enters Into Licensing Agreement with GenSignia IP
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test
Trovagene Enters into Agreement with Novogene
Trovagene Enters into Agreement for Trovera
Trovagene Enters into Agreement with AstraZeneca
Trovagene Enter into Agreements for Trovera
Trovagene Enters into Agreement with Boreal Genomics
Trovagene Enters into Agreement with USC Norris Comprehensive Cancer Center
Trovagene Enters into Research Agreement with University of Michigan Comprehensive Cancer Center
Trovagene Enters into Patent Option Agreement with Massachusetts Institute of Technology
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University
Trovagene Raises USD18 Million in Public Offering of Shares
Trovagene Raises USD4.5 Million in Public Offering of Shares and Warrants
Trovagene Plans to Raise Funds through Public Offering of Shares upon Exercise of Warrants
Trovagene Raises USD7.1 Million in Private Placement of Shares and Warrants
Trovagene Raises USD40.3 Million in Public Offering of Shares
Trovagene Completes Public Offering of Shares for USD23 Million
Trovagene Completes Private Placement Of Shares For US$15 Million
Trovagene Completes Private Placement Of Units For US$4 Million
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million
Trovagene Inc, Key Competitors
Trovagene Inc, Key Employees

LIST OF FIGURES

Trovagene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Trovagene Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018
Skip to top


Ask Your Question

Trovagene Inc (TROV) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: